Literature DB >> 12619882

Characterisation of nuclear pore complex oxalate binding protein from human kidney.

R Selvam1, R Vijaya, P Sivakamasundari.   

Abstract

Both rat and human kidney nuclei exhibited time and pH dependent oxalate or histone-oxalate uptake which was inhibited by anion transport inhibitor, 4,4'-dithiocyanostilbene-2,2'-disulphonic acid. Sodium chloride had no effect. Nuclear membrane had oxalate binding at pH 7.4. Extraction of nuclear membrane by Triton-high salt mixture showed maximal oxalate binding activity with nuclear pore complex while nuclear lamin had no oxalate binding. The rat and human kidney nuclear pore complex showed oxalate binding of 144 and 220 pmoles/mg protein respectively. Subsequent purification of the protein on diethyl amino ethyl-Sephadex A 50 column and Sephadex G-200 column yielded 4-fold purification. The protein revealed a molecular weight of 205 kDa on SDS-PAGE. The protein was found to be saturable at 2 microM oxalate and had a Kd of 2.98 pM and a Bmax of 197 pmoles. Antibody for 205 kD was separated from primary biliary cirrhosis serum containing auto antibody against 205 kDa using affinity column chromatography. The oxalate binding activity as well as the nuclear uptake of oxalate or histone-oxalate were inhibited by its antibody.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619882     DOI: 10.1023/a:1021641223419

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

1.  Facilitated nuclear transport of histone H1 and other small nucleophilic proteins.

Authors:  M Breeuwer; D S Goldfarb
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

2.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Oxalate transport in renal tubular cells from normal and stone-forming animals.

Authors:  D Sigmon; S Kumar; B Carpenter; T Miller; M Menon; C Scheid
Journal:  Am J Kidney Dis       Date:  1991-04       Impact factor: 8.860

5.  Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210.

Authors:  C Favreau; H J Worman; R W Wozniak; T Frappier; J C Courvalin
Journal:  Biochemistry       Date:  1996-06-18       Impact factor: 3.162

6.  Characterization of nuclear oxalate binding protein of rat and human kidney.

Authors:  R Selvam; K Kannabiran
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

7.  Identification and purification of a calcium-binding protein in hepatic nuclear membranes.

Authors:  J S Gilchrist; G N Pierce
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

8.  Primary structure analysis of an integral membrane glycoprotein of the nuclear pore.

Authors:  R W Wozniak; E Bartnik; G Blobel
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

9.  Monoclonal antibodies identify a group of nuclear pore complex glycoproteins.

Authors:  C M Snow; A Senior; L Gerace
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

10.  Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.

Authors:  R E Nickowitz; H J Worman
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  2 in total

1.  Estrogen receptor β and its domains interact with casein kinase 2, phosphokinase C, and N-myristoylation sites of mitochondrial and nuclear proteins in mouse brain.

Authors:  Vijay Paramanik; Mahendra Kumar Thakur
Journal:  J Biol Chem       Date:  2012-05-07       Impact factor: 5.157

2.  Nuclear Pore Protein p62 Autoantibodies in Systemic Lupus Erythematosus.

Authors:  Doris M Kraemer; Hans-Peter Tony
Journal:  Open Rheumatol J       Date:  2010-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.